Kamada (KMDA) Restructuring Costs (2021)
Kamada (KMDA) reported Restructuring Costs of -$95.0 million for Q4 2021, down 6666.31% quarter-over-quarter from -$1.4 million in Q1 2021.
Kamada (KMDA) Restructuring Costs (2021) Analysis & Trends
Kamada has reported Restructuring Costs for 1 years, with the latest figure at -$95.0 million in Q4 2021.
- For the quarter ending Q4 2021, Restructuring Costs changed N/A year-over-year to -$95.0 million; the trailing twelve-month figure through Dec 2021 stood at -$96.4 million (changed N/A YoY), and the FY2021 full-year result was -$96.4 million, changed N/A from the prior year.
- Restructuring Costs for Q4 2021 stood at -$95.0 million, down from -$1.4 million in the prior quarter.
- The five-year high for Restructuring Costs was -$1.4 million in Q1 2021, with the low at -$95.0 million in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Kamada | 505.05 | -73.15 Mn | 19.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -95.00 Mn |
| Mar 31, 2021 | -1.40 Mn |